Progression of Pancreatic Cancer Inhibited by Nanomedicine in Mice

News   Jan 03, 2018 | Original story from Tel Aviv University

 
Progression of Pancreatic Cancer Inhibited by Nanomedicine in Mice
 
 
 

RELATED ARTICLES

Fragile X: Drug Strategy Could Alleviate Behavioral & Cellular Deficiencies

News

Research in mice shows that a pharmacological strategy can alleviate multiple behavioral and cellular deficiencies in a mouse model of fragile X syndrome (FXS), the most common inherited form of intellectual disability and a major single-gene cause of autism spectrum disorders.

READ MORE

Mouse Study Suggests That Dietary Fat, Not Carbs, Drives Obesity

News

A mouse study that made over 100,000 measurements of body weight and fat has concluded that the sole driver of obesity in mice is increased dietary fat content.

READ MORE

Testosterone Effective at Combating Cachexia in Cancer Patients

News

Many cancer patients suffer from a loss of body mass known as cachexia. A new study shows that the hormone testosterone is effective at combatting cachexia in cancer patients and improving quality of life.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cancer Research Cell Science Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy